Bioventus (BVS) executive compensation, 2026 proxy

Robert E. Claypoole, President & Chief Executive Officer, was paid $4.3M in 2025, down 33% from $6.4M the year before.

Filed
April 22, 2026
Annual meeting
June 3, 2026
Pay year
2025
Named executives
3
CEO total pay
$4.3M-33% vs prior year
CEO pay in equity
62%$2.6M in awards
CEO 2025 Total Pay
$4.3MDown from prior year
CEO Target Incentive
100%Of eligible earnings
AIP Achievement Payout
94.8%For objective business measures

How Claypoole was paid

$4.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary19%Stock awards46%Option awards15%Non-equity incentive18%All other compensation1%

Named executive officers

ExecutiveTotal
Robert E. ClaypoolePresident & Chief Executive Officer$4,299,108
Mark SingletonSenior Vice President & Chief Financial Officer$1,897,062
Anthony D'AdamioSenior Vice President & General Counsel$1,409,989

What changed and why

  • $4.3MCEO Robert E. Claypoole received total compensation of $4,299,108 in 2025, down from $6,379,010 in 2024.
  • The decrease in CEO pay was primarily driven by the absence of a one-time hiring bonus received in 2024.
  • 94.8%The 2025 short-term incentive cash payments were based on an achievement percentage of 94.8% for objective business performance measures.
  • 2025 was the first year the company granted performance restricted stock units subject to relative total shareholder return.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.